1. Home
  2. MSBI vs INBX Comparison

MSBI vs INBX Comparison

Compare MSBI & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSBI
  • INBX
  • Stock Information
  • Founded
  • MSBI 1881
  • INBX 2010
  • Country
  • MSBI United States
  • INBX United States
  • Employees
  • MSBI N/A
  • INBX N/A
  • Industry
  • MSBI Major Banks
  • INBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSBI Finance
  • INBX Health Care
  • Exchange
  • MSBI Nasdaq
  • INBX Nasdaq
  • Market Cap
  • MSBI 392.8M
  • INBX 345.8M
  • IPO Year
  • MSBI 2016
  • INBX 2020
  • Fundamental
  • Price
  • MSBI $17.63
  • INBX $26.57
  • Analyst Decision
  • MSBI Hold
  • INBX Hold
  • Analyst Count
  • MSBI 3
  • INBX 2
  • Target Price
  • MSBI $20.67
  • INBX N/A
  • AVG Volume (30 Days)
  • MSBI 114.5K
  • INBX 112.0K
  • Earning Date
  • MSBI 10-23-2025
  • INBX 11-13-2025
  • Dividend Yield
  • MSBI 7.05%
  • INBX N/A
  • EPS Growth
  • MSBI N/A
  • INBX N/A
  • EPS
  • MSBI N/A
  • INBX N/A
  • Revenue
  • MSBI $224,320,000.00
  • INBX $1,400,000.00
  • Revenue This Year
  • MSBI $27.04
  • INBX N/A
  • Revenue Next Year
  • MSBI N/A
  • INBX N/A
  • P/E Ratio
  • MSBI N/A
  • INBX N/A
  • Revenue Growth
  • MSBI N/A
  • INBX N/A
  • 52 Week Low
  • MSBI $14.79
  • INBX $10.81
  • 52 Week High
  • MSBI $28.08
  • INBX $30.23
  • Technical
  • Relative Strength Index (RSI)
  • MSBI 44.12
  • INBX 52.85
  • Support Level
  • MSBI $17.70
  • INBX $27.51
  • Resistance Level
  • MSBI $18.23
  • INBX $28.86
  • Average True Range (ATR)
  • MSBI 0.42
  • INBX 1.48
  • MACD
  • MSBI -0.08
  • INBX -0.30
  • Stochastic Oscillator
  • MSBI 11.89
  • INBX 26.21

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: